Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Compare to the live pageView snapshot

Earlier capture

Drugs - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 249993

Original URL ↗
View snapshot

Later capture

Drugs - Canada.ca

Jan 2, 2026

hc-20260101

ID 428854

Original URL ↗
View snapshot
updated3 sections changed
3 sections changed0 added0 removed+0 / -4 linesChange ratio: 2%
---
+++
@@ -32,8 +32,6 @@
Advisories for Health Professionals or Consumers
APIPL/ARPL/IPCA
Micro Labs
-Dr. Reddy's Laboratories / IPCA Laboratories
-Sri Krishna Pharmaceuticals Ltd
Active Ingredients
Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients for Veterinary Use
Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients
@@ -90,11 +88,9 @@
Good Pharmacovigilance Practices (GVP) Guidelines (GUI-0102)
Risk Classification of Good Pharmacovigilance Practices (GVP) Observations (GUI-0063)
Inspection Strategy for Good Pharmacovigilance Practices for Drugs (POL-0041)
-Summary Report of the Post-Market Reporting Compliance Inspections Conducted from September 1, 2005 to March 31, 2008
Recalls
Product Recall Procedures
Veterinary
Policy for the Importation or Sale of Active Pharmaceutical Ingredients for Veterinary Use
Page details
-Date modified:
2022-09-29